Stocks are stagnating lower on Thursday, but arenât declining with any real staying power. As boring as that action can be, investors need to be careful not to overtrade. If need be, walk away from your desk for a while and get some fresh air. Then come back and letâs talk about some top stock trades.
Shares of Rite Aid (NYSE:RAD) are making new lows (what else is new) as the company reported fourth-quarter earnings. RAD missed on earnings and revenue estimates, provided weak guidance and announced 1:20 reverse split.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Letâs put it this way: A healthy company doesnât reverse split.
Weâve said to avoid RAD stock over and over throughout the years. The company is circling the drain and thereâs no reason to trade this one when thereâs so many other options out there. Even shorts can be burned by a temporary squeeze.
A cheap valuation, decent growth and a solid dividend arenât enough to support CVS Health (NYSE:CVS). I highlighted this one as a trade last month before shares promptly jumped about 10%. Since then though, the stock has come back down to this $52 level twice now.
If it gets there again, will it hold as support? The chart looks grim and while I was a buyer on the initial test of $52, Iâm not now. Thereâs no telling where this will find support if the recent lows give way.
On the upside, CVS needs to get above downtrend resistance and the 20-day moving average.
UnitedHealth (NYSE:UNH) has a similar chart, with downtrend resistance squeezing the share price into repeated support. Uptrend support (purple line) has given way, so itâs all up to bulls to step up to the plate between Thursdayâs lows and $235.
A drop below $230 puts UNH in no manâs land for the time being. If it holds, see if UNH can get above $246 to $250 on a rally.
Remember when we talked about the very slow consolidation in Canopy Growth (NYSE:CGC) stock a few months ago? We ended up stopping out of this one as uptrend support and the 50-day moving average gave way.
It looked like $42 was going to hold up as support, but it wasnât worth the risk to us. As you can see in April though, $42 actually turned into resistance after acting as temporary support.
CGC may pull in some buyers near the 200-day, but cannabis stocks like CGC, Cronos Group (NASDAQ:CRON), Tilray (NASDAQ:TLRY) and others are under pressure. Itâs not clear yet whether the 200-day will act as support.
If it does, bulls have a clear line in the sand. If not, look for potential short-term support in the $37 to $38 area. Below that and ~$34 is in the cards.
Disappointing late-stage data disappointed investors in Intercept Pharmaceuticals (NASDAQ:ICPT), which is down almost 13% on the day as a result.
Prior resistance near $115 did not act as support, as ICPT is knifing through all three major moving averages on Thursday. Itâs not a good look for bulls. If ICPT canât get back above the 200-day and 50-day moving averages, or if it does temporarily but they turn into resistance, then the stock could be heading lower.
If thatâs the case, a test of uptrend support is certainly possible, currently about $15 or 14.3% below current levels. If shares bounce from current levels, look for a retest of $115 and see how ICPT does then.
Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities.
Compare Brokers
The post 5 Top Stock Trades for Friday: CGC, CVS, ICPT, RAD, UNH appeared first on InvestorPlace.